Literature DB >> 27163528

TMEPAI increases lysosome stability and promotes autophagy.

Shenheng Luo1, Meng Yang1, Dan Lv1, Lei Jing1, Yuyin Li1, Zhenxing Liu1, Aipo Diao2.   

Abstract

Autophagy is emerging as a critical response of normal and cancer cells to environmental changes and plays an important role in cell metabolism and maintenance of damaged organelles. Transmembrane prostate androgen-induced protein (TMEPAI) is a pro-tumorigenic factor with high expression in tumor cells. In this study, we showed that depletion of TMEPAI leads to lysosomal labilization and inhibits autophagy. Further study showed that the inhibition of autophagy induced by the depletion of TMEPAI is involved in regulation of Beclin-1. Depletion of TMEPAI increases the sensitivity of cancer cells to chemotherapeutic drugs. Our study reveals the role of TMEPAI in promoting lysosome stability and autophagy, which might be used as a target for cancer chemotherapeutic treatment.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autophagy; Beclin-1; Cancer cell; Lysosome; TMEPAI

Mesh:

Substances:

Year:  2016        PMID: 27163528     DOI: 10.1016/j.biocel.2016.05.004

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  5 in total

1.  2-(2-nitrobenzylidene) indolin-3-one compound inhibits transmembrane prostate androgen-induced protein (TMEPAI) expression and cancer cell proliferation.

Authors:  Yuyin Li; Jianjun Wang; Ning Song; Feihong Zeng; Miaomiao Zhao; Ali Wang; Yue Chen; Lei Jing; Peng Yu; Aipo Diao
Journal:  Cell Prolif       Date:  2018-08-02       Impact factor: 6.831

2.  The transmembrane protein TMEPAI induces myeloma cell apoptosis by promoting degradation of the c-Maf transcription factor.

Authors:  Yanyun Du; Yan Liu; Yujia Xu; Jiaxiang Juan; Zubin Zhang; Zhuan Xu; Biyin Cao; Qi Wang; Yuanying Zeng; Xinliang Mao
Journal:  J Biol Chem       Date:  2018-02-21       Impact factor: 5.157

3.  Ubiquitination and dynactin regulate TMEPAI lysosomal trafficking.

Authors:  Shenheng Luo; Lei Jing; Tian Zhao; Yuyin Li; Zhenxing Liu; Aipo Diao
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

4.  TGF-β-Induced TMEPAI Promotes Epithelial-Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration.

Authors:  Bantari W K Wardhani; Melva Louisa; Yukihide Watanabe; Rianto Setiabudy; Mitsuyasu Kato
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-09-21

5.  TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel.

Authors:  Bantari Wk Wardhani; Meidi Utami Puteri; Yukihide Watanabe; Melva Louisa; Rianto Setiabudy; Mitsuyasu Kato
Journal:  J Exp Pharmacol       Date:  2020-01-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.